✦ LIBER ✦

9163 Phase I dose-escalation study of vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small-cell lung cancer (NSCLC)

✍ Scribed by Teixeira, L.; Descourt, R.; Moro-Sibilot, D.; Misset, J.L.; Gachard, E.; Rizvi, S.; Roben, E.; Zalcman, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin + gemcitabine in non-small cel

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Phase I study of escalating doses of oxa

✍ Bidoli, P 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Sunitinib in combination with gemcitabin

✍ Reck, Martin; Frickhofen, Norbert; Cedres, Susana; Gatzemeier, Ulrich; Heigener, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 210 KB

6607 POSTER Preliminary findings of a ph

✍ Reck, M.; Frickhofen, N.; Gatzemeier, U.; Fuhr, H.G.; Lanzalone, S.; Wang, E.; C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Vorinostat, a Histone Deacetylase Inhibi

✍ Decker, R.H.; Gettinger, S.N.; Glazer, P.M.; Wilson, L.D. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

1081 Gemcitabine combined with cisplatin

✍ Steward, W.P.; Dunlop, D.J.; Cameron, C.; Talbot, D.C.; Kleisbauer, J.-P.; Thoma 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 158 KB